Trial Profile
A study to evaluate safety and efficacy of Etanercept as monotherapy in patients with psoriasis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Aug 2017
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 08 Aug 2017 New trial record
- 03 Aug 2017 Results of pooled analysis of 10 trials (NCT00245960, NCT00111449, NCT00663052, NCT00454584) generating evidence concerning the number of patients dropping out of etanercept trials published in the British Journal of Dermatology
- 20 Nov 2003 Results published in the New England Journal of Medicine